Glaxo's Avandia Study Results Rebut Heart-Attack ConcernsWall Street JournalNEW ORLEANS (Dow Jones)--GlaxoSmithKline PLC (GSK) on Friday unveiled a study showing its troubled diabetes drug Avandia doesn't increase patients' risk for heart attacks, but leading cardiologists remain unconvinced, saying the company's research has ...Major study clears Glaxo's Avandia of heart risk ReutersGlaxo Fails To Learn Lesson of Avandia ForbesMedPage Today - Market Wire (press release) - Medical News Today - Local Tech Wireall 38 news articles

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News